【ChiCTR2500113086】Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
ChiCTR2500113086
尚未开始
/
/
/
2025-11-24
/
/
Insomnia and anxiety
Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
1.To compare the effect of dCBT-I, dBT-I-ACT and Health Education in improving anxiety symptoms in youth 2.To compare the effect of dCBT-I, dBT-I-ACT and Health Education in improving insomnia symptoms in youth 3.To compare the effect of dCBT-I, dBT-I-ACT and Health Education in improving depressive symptoms, cognitive flexibility, dysfunctional beliefs about sleep, pre-sleep hyperarousal, and quality of life in youth
随机平行对照
其它
Stratified randomization will be employed to balance gender and age distribution.
The data analyst will remain blinded to group allocation to prevent expectation or analysis bias.
None
/
72
/
2025-11-24
2027-11-30
/
i.Chinese youth aged 15-24 years old, ii.Presence of acute insomnia disorder as determined by validated Diagnostic Interview for Sleep Patterns and Disorders (DISP), iii.Presence of anxiety features as defined by General Anxiety Disorder-7 (GAD-7) using cut-off of 15 for detecting moderate anxiety symptoms, iv.Ability to listen, speak, and read Chinese and Cantonese, and v.Written informed consent of participation into the study is given by youth and his/her parent’s if under 18 years old; In addition, individual assent will also be obtained for subjects under age 18 years old vi.Possession of a smartphone;
请登录查看i.A clinical diagnosis of psychosis, schizophrenia, bipolar disorders, or intellectual disability, ii.Having a diagnosed sleep disorder (e.g. delayed sleep phase and narcolepsy) that may potentially contribute to the disruption of sleep quantity and quality as determined by validated Diagnostic Interview for Sleep Patterns and Disorders (DISP), iii.Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt) as assessed by The Structured Clinical Interview (SCID), and iv.Currently receiving psychological treatment and/or pharmacological treatment for insomnia or anxiety disorder.;
请登录查看The Chinese University of Hong Kong
/
The Chinese University of Hong Kong的其他临床试验
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- Effects of Wearing a Sauna Suit During High-Intensity Interval Exercise
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial
- The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses
- An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial
- Effectiveness of acceptance-based diabetes self-management (ACT-DSM) for adults with type 2 diabetes for improving diabetes distress and glycaemic control: A randomised controlled trial
- Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
- The effects of art therapy-based intervention on anxiety children with haematological cancers: a randomised controlled trial
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
- An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial
- WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery
- Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Hepatobiliary and Pancreatic surgery
- A pilot study on the efficacy and safety of the use of a synbiotic formula (SCV09) in people with Mild Cognitive Impairment (MCI)
- The effects of theory-guided multimodal educational (TIME) programme on the faecal occult blood test uptake rates among adults at average-risk of colorectal cancer: A randomized controlled trial
- 使用視網膜圖像分析來評估狗主人的認知健康風險的初步研究
- A Multilevel Implementation Study for Physical Activity Promotion in Children with Disabilities
- Effects of dance-based multimodal exercise programme for managing chemotherapy-induced peripheral neuropathy in patients with colorectal cancer: A randomized controlled study
Department of Psychiatry, The Chinese University of Hong Kong的其他临床试验
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
- 定位連環透顱磁力剌激對認知障礙症患者抑鬱徵狀的療效研究
- 運動訓練與工作記憶訓練對減慢輕度阿氏痴呆症長者認知能力下降之隨機對比研究
- 個人化身心運動治療對抑鬱症及焦慮症之隨機對照臨床試驗效果研究
- A randomized controlled trial of leisure activity intervention on preservation of cognitive and everyday function in Chinese older adults with early cognitive decline
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-10
-
2026-09-09
-
2026-09-08
-
摩熵咨询 20 5
-
摩熵咨询 20 8
-
摩熵咨询 34 43
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-10
-
2026-09-10
-
2026-09-10
-
摩熵咨询 35 60
-
摩熵咨询 28 52
-
摩熵咨询 34 37
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29

